Progress in the diagnosis and treatment of radiotherapy for cardiac metastases
10.3760/cma.j.cn113030-20230804-00040
- VernacularTitle:心脏转移瘤放疗的研究进展
- Author:
Tie XU
1
;
Jun LIANG
1
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院深圳医院放疗科，深圳 518116
- Publication Type:Journal Article
- Keywords:
Neoplasm metastasis, cardiac;
Radiotherapy;
Progress
- From:
Chinese Journal of Radiation Oncology
2025;34(3):295-299
- CountryChina
- Language:Chinese
-
Abstract:
Cardiac tumors are rare, and the majority of them are metastatic. Most patients with cardiac metastasis are in the terminal stage of cancer, and the 5-year survival rate is almost zero. Due to the low morbidity, there is no standard therapy for the management of patients with cardiac metastases. The use of palliative radiotherapy in patients with cardiac metastasis is limited due to the adverse cardiac effects caused by radiotherapy. This article reviews the practice and progress in radiotherapy for patients with cardiac metastases from the aspects of positioning, target delineation, dose setting, organ at risk limit, and side effects.
